Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7304113
[patent_doc_number] => 20040115649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Modulation of ABCC5 expression'
[patent_app_type] => new
[patent_app_number] => 10/319893
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21734
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10319893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/319893 | Modulation of ABCC5 expression | Dec 11, 2002 | Abandoned |
Array
(
[id] => 7304036
[patent_doc_number] => 20040115635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Modulation of PTPN13 expression'
[patent_app_type] => new
[patent_app_number] => 10/317401
[patent_app_country] => US
[patent_app_date] => 2002-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20275
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10317401
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/317401 | Modulation of PTPN13 expression | Dec 10, 2002 | Abandoned |
Array
(
[id] => 7304035
[patent_doc_number] => 20040115634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Modulation of stat 6 expression'
[patent_app_type] => new
[patent_app_number] => 10/317391
[patent_app_country] => US
[patent_app_date] => 2002-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21536
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115634.pdf
[firstpage_image] =>[orig_patent_app_number] => 10317391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/317391 | Modulation of stat 6 expression | Dec 10, 2002 | Abandoned |
Array
(
[id] => 7155918
[patent_doc_number] => 20050026855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Therapeuticum and prophylacticum for malignant diseases using phenotype suppression'
[patent_app_type] => utility
[patent_app_number] => 10/498795
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5696
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026855.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498795 | Therapeuticum and prophylacticum for malignant diseases using phenotype suppression | Dec 9, 2002 | Abandoned |
Array
(
[id] => 7289194
[patent_doc_number] => 20040110159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Modulation of estrogen-responsive finger protein expression'
[patent_app_type] => new
[patent_app_number] => 10/317277
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20568
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110159.pdf
[firstpage_image] =>[orig_patent_app_number] => 10317277
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/317277 | Modulation of estrogen-responsive finger protein expression | Dec 9, 2002 | Abandoned |
Array
(
[id] => 7289188
[patent_doc_number] => 20040110158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Modulation of mitochondrial ribosomal protein L13 expression'
[patent_app_type] => new
[patent_app_number] => 10/317273
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20115
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10317273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/317273 | Modulation of mitochondrial ribosomal protein L13 expression | Dec 9, 2002 | Abandoned |
Array
(
[id] => 7305946
[patent_doc_number] => 20040116365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Modulation of Lck expression'
[patent_app_type] => new
[patent_app_number] => 10/316515
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20376
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10316515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/316515 | Modulation of Lck expression | Dec 9, 2002 | Abandoned |
Array
(
[id] => 7290833
[patent_doc_number] => 20040110703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Modulation of DR1-associated protein 1 expression'
[patent_app_type] => new
[patent_app_number] => 10/317279
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19178
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10317279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/317279 | Modulation of DR1-associated protein 1 expression | Dec 9, 2002 | Abandoned |
Array
(
[id] => 7289152
[patent_doc_number] => 20040110145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Modulation of MALT1 expression'
[patent_app_type] => new
[patent_app_number] => 10/316241
[patent_app_country] => US
[patent_app_date] => 2002-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19170
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110145.pdf
[firstpage_image] =>[orig_patent_app_number] => 10316241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/316241 | Modulation of MALT1 expression | Dec 8, 2002 | Abandoned |
Array
(
[id] => 7465669
[patent_doc_number] => 20040101853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Modulation of STAT2 expression'
[patent_app_type] => new
[patent_app_number] => 10/304103
[patent_app_country] => US
[patent_app_date] => 2002-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21094
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20040101853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304103 | Modulation of STAT2 expression | Nov 22, 2002 | Abandoned |
Array
(
[id] => 6740780
[patent_doc_number] => 20030158149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Method of treating hepatitis delta virus infection'
[patent_app_type] => new
[patent_app_number] => 10/302814
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17131
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302814 | Method of treating hepatitis delta virus infection | Nov 21, 2002 | Issued |
Array
(
[id] => 7469123
[patent_doc_number] => 20040102403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Modulation of fibrillarin expression'
[patent_app_type] => new
[patent_app_number] => 10/304111
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21318
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304111 | Modulation of fibrillarin expression | Nov 20, 2002 | Abandoned |
Array
(
[id] => 612807
[patent_doc_number] => 07148204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-12
[patent_title] => 'Antisense modulation of bcl-x expression'
[patent_app_type] => utility
[patent_app_number] => 10/302262
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28657
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/148/07148204.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302262
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302262 | Antisense modulation of bcl-x expression | Nov 20, 2002 | Issued |
Array
(
[id] => 7474180
[patent_doc_number] => 20040097448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Modulation of CD24 expression'
[patent_app_type] => new
[patent_app_number] => 10/300236
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20500
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10300236
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/300236 | Modulation of CD24 expression | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6740272
[patent_doc_number] => 20030157641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Polycistronic expression of antibodies'
[patent_app_type] => new
[patent_app_number] => 10/295823
[patent_app_country] => US
[patent_app_date] => 2002-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 84
[patent_figures_cnt] => 84
[patent_no_of_words] => 18095
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157641.pdf
[firstpage_image] =>[orig_patent_app_number] => 10295823
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/295823 | Polycistronic expression of antibodies | Nov 17, 2002 | Abandoned |
Array
(
[id] => 7474138
[patent_doc_number] => 20040097442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Modulation of BRCA2 region transcription unit CG005 expression'
[patent_app_type] => new
[patent_app_number] => 10/298354
[patent_app_country] => US
[patent_app_date] => 2002-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20050
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097442.pdf
[firstpage_image] =>[orig_patent_app_number] => 10298354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/298354 | Modulation of BRCA2 region transcription unit CG005 expression | Nov 15, 2002 | Abandoned |
Array
(
[id] => 7470507
[patent_doc_number] => 20040096830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Modulation of protein kinase D2 expression'
[patent_app_type] => new
[patent_app_number] => 10/298123
[patent_app_country] => US
[patent_app_date] => 2002-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19726
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20040096830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10298123
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/298123 | Modulation of protein kinase D2 expression | Nov 15, 2002 | Abandoned |
Array
(
[id] => 7467788
[patent_doc_number] => 20040053864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Methods and compositions for control of bone formation via modulation of neuropeptide y activity'
[patent_app_type] => new
[patent_app_number] => 10/181906
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 34629
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181906 | Methods and compositions for control of bone formation via modulation of neuropeptide y activity | Nov 12, 2002 | Abandoned |
Array
(
[id] => 7367411
[patent_doc_number] => 20040092465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Modulation of huntingtin interacting protein 1 expression'
[patent_app_type] => new
[patent_app_number] => 10/293864
[patent_app_country] => US
[patent_app_date] => 2002-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20652
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092465.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293864 | Modulation of huntingtin interacting protein 1 expression | Nov 10, 2002 | Abandoned |
Array
(
[id] => 6869459
[patent_doc_number] => 20030082148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo'
[patent_app_type] => new
[patent_app_number] => 10/286385
[patent_app_country] => US
[patent_app_date] => 2002-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18682
[patent_no_of_claims] => 131
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082148.pdf
[firstpage_image] =>[orig_patent_app_number] => 10286385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/286385 | Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo | Oct 30, 2002 | Abandoned |